IL-1 receptor based antagonists and methods of making and using

Details for Australian Patent Application No. 2003284895 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Stahl, Neil; Yancopoulos, George D.

Agent Davies Collison Cave

Pub. Number AU-B-2003284895

PCT Number PCT/US2003/0337

PCT Pub. Number WO2004/039951

Priority 10/282,162 28.10.02 US

Filing date 24 October 2003

Wipo publication date 25 May 2004

Acceptance publication date 5 November 2009

International Classifications

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 10/282,162 28.10.02 US

24 June 2004 Application Open to Public Inspection

  Published as AU-B-2003284895

5 November 2009 Application Accepted

  Published as AU-B-2003284895

4 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003284896-METHOD FOR MAKING STABLE, HOMOGENEOUS MELT SOLUTIONS

2003284894-AN ASSOCIATIVE ANALYSIS OF GENE EXPRESSION ARRAY DATA